Keywords: نورآمینیداز; SA; sialic acid; NA; neuraminidase; TLPs; triple-layered particles; SC; serocolostrum; BM; buttermilk; BS; butter serum; MFGM; milk fat globule membrane; WPC; whey protein concentrate; IgG; immunoglobulin G; LF; lactoferrin; MUCs; mucins; LDH; lactadherin
مقالات ISI نورآمینیداز (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: نورآمینیداز; Influenza; Neuraminidase; dN/dS ratio; Overall selection; Positively selected sites; Site-specific selective pressures;
Keywords: نورآمینیداز; ANSES; French Agency for Food, Environmental and Occupational Health and Safety; AUC; area under the curve; CFSE; carboxyfluorescein succinimidyl ester; EMEM; Eagle's minimum essential medium; FBS; fetal bovine serum; HA; hemagglutinin; HAU; hemagglutin
Keywords: نورآمینیداز; Enzyme immobilization; Neuraminidase; Magnetic beads; Screening inhibitors;
Keywords: نورآمینیداز; Influenza; Neuraminidase; Inhibitor; Susceptibility; Surveillance; Resistance;
Keywords: نورآمینیداز; Fast pulling of ligand; Neuraminidase; NEMD; Absolute affinity; Interaction energy; Pulling work;
Keywords: نورآمینیداز; IAV; influenza A virus; CPE; cytopathic effect; TCID50; 50% tissue culture infective dose; RCA; rapid culture assay; IVT; infectious virus titer; NP; nucleoprotein; MAb; monoclonal antibody; TCA; trichloroacetic acid; MDCK; Madin-Darby canine kidney; HA;
Keywords: نورآمینیداز; Equine influenza; Epidemic; Re-assortment; Phylogenetic; Equine; Pakistan; EIV; equine influenza virus; FC-1; Florida clade 1; FC-2; Florida clade 2; HA; hemagglutinin; NA; neuraminidase; OIE; Office International des Epizooties (World Organization for An
Keywords: نورآمینیداز; Neuraminidase; Label-free electrochemical biosensor; Whole blood analysis; Influenza virus; Clinical diagnosis; Biomedical applications;
Keywords: نورآمینیداز; Neuraminidase; Inhibitor; Susceptibility; Surveillance; Resistance; Markers;
Keywords: نورآمینیداز; HA; hemagglutinin; NA; neuraminidase; RBS; receptor-binding site; CDR; complementarity-determining region; bnAbs; broadly neutralizing antibodies; Fab; fragment antigen binding; influenza A virus; hemagglutinin; protein structure; evolution; antibody;
Keywords: نورآمینیداز; CMC; manufacturing and controls; HA; haemagglutinin antigen; HPV; human papillomavirus; MenACWY; meningococcal (serogroups A,C,W,Y) oligosaccharide conjugate vaccine; NA; neuraminidase; Vaccine; Quality control; Manufacturing; Cold chain; Supply;
Keywords: نورآمینیداز; Neuraminidase; Molecular dynamics simulation; 340-cavity; Hotspot;
Keywords: نورآمینیداز; Antiviral; Solid-state copper and silver compounds; Hemagglutinin; Neuraminidase; Protein denaturation;
Keywords: نورآمینیداز; Gold nanoparticle; Zanamivir; Neuraminidase; Electroanalysis; Enzymatic inhibitionNA, neuraminidase; ELISA, enzyme-linked immunosorbent assay; Au–BDD, gold-modified boron-doped diamond; BDD, boron-doped diamond; AuNPs, gold nanoparticles; LOD, limit of de
Keywords: نورآمینیداز; HA; hemagglutinin; NA; neuraminidase; HI; hemagglutination inhibition; HAU; hemagglutination unit; MN; microneutralization; LD50; 50% lethal dose; PFU; plaque forming unit; Influenza virus; Infection; Antigenic drift; Vaccine efficacy; Pandemic H1N1;
Keywords: نورآمینیداز; Sialic acids; Neuraminidase; Chemoenzymatic labeling; Microarray
Keywords: نورآمینیداز; CER; ceramide; C9-4HMT-DANA; 9-[4-hydroxymethyl-[1,2,3]triazol-1-yl]-2,3-didehydro-N-acetyl-neuraminic acid; DANA; 2,3-didehydro-N-acetyl-neuraminic acid; ECM; extracellular matrix; FN; fibronectin; hNeu; human neuraminidase enzyme; HPTLC; high performanc
Keywords: نورآمینیداز; LC; liquid-chromatography; MS; mass spectrometry; HA; hemagglutinin; NA; neuraminidase; SRID; single radial immunodiffusion assay; WHO; World Health Organization; RP; reversed-phase chromatography; SEC; size-exclusion chromatography; IEX; ion-exchange c
Keywords: نورآمینیداز; NA; neuraminidase; IC50; amount of drug to reduce enzyme activity by 50%; ELISA; enzyme linked immunosorbent assay; Influenza; Laninamivir; Resistance; Enzyme kinetics;
Keywords: نورآمینیداز; Antivirals; influenza; inhibitors; neuraminidase; treatment;
Keywords: نورآمینیداز; Macromolecular surface; Description; Neuraminidase; Allosteric; Deformable; Heat kernel; Fractional;
Keywords: نورآمینیداز; ALP; alkaline phosphatase; BC; bone cylinder; BM; bone marrow; BMV; bone matrix vesicle; Hb; hemoglobin; MW; molecular weight; NA; neuraminidase; PAGE; polyacrylamide gel electrophoresis; PB; peripheral blood; PI-PLC; phosphatidyl-inositol-phospholipase C
Keywords: نورآمینیداز; Pneumococci; Neuraminidase; NanA; Neuraminidase inhibitors; Oseltamivir; Zanamivir; DANA; Katsumadain A; Artocarpin; Antipneumococcal; Biofilm;
Keywords: نورآمینیداز; HIV; Human Immunodeficiency Virus; rDNA; recombinant DNA technology; MHC; major histocompatibility complex; HLA; human leukocyte antigen; PSSM; Position Specific Scoring Matrices; ANN; Artificial Neuronal Networks; QM; quantitative matrices; KISS; Kernel-
Keywords: نورآمینیداز; 293T; human embryonic kidney cells; BSA; bovine serum albumin; cDNA; complementary deoxyribonucleic acid; CEF; chicken embryo fibroblasts; Cyt.D; cytochalasin D; DAPI; 4â²,6-diamidino-2-phenylindole; DEF; duck embryo fibroblasts; DM; dissociation medium;
Keywords: نورآمینیداز; CMI; cellular mediated immunity; CoP; correlate of protection; ELISA; enzyme-linked immunosorbent assay; HA; haemagglutinin; HI; haemagglutination inhibition assay; HPAIV; highly pathogenic avian influenza viruses; HPLC; high-performance liquid chromatogr
Keywords: نورآمینیداز; Influenza; Vaccines; Neuraminidase; Stability; Immunogenicity
Keywords: نورآمینیداز; NA; neuraminidase; NAI; neuraminidase inhibitor; IC50; drug concentration which reduces enzyme activity by 50% compared to untreated enzyme; Influenza; Neuraminidase inhibitors; Reactivation; Drug resistance; Mutants;
Keywords: نورآمینیداز; Influenza; Neuraminidase; Flavonoids; Molecular dynamics; Docking;
Keywords: نورآمینیداز; ELLA; enzyme-linked lectin assay; HA; hemagglutinin; HI; HA inhibition; NA; neuraminidase; NI; NA inhibiting/inhibition; PBS; phosphate-buffered saline; PNA; peanut agglutinin; TBA; thiobarbituric acid; Influenza; Neuraminidase; Enzyme-linked lectin assay
Keywords: نورآمینیداز; Anthocyanidin; Inhibitor; Influenza; Neuraminidase; MALDI; Mass spectrometry
Keywords: نورآمینیداز; Influenza; Virus; Neuraminidase; Inhibitor; Pharmacokinetics; Molecular modeling; BQLKEXSYWRBWQK-AFMQGRBTSA-N; AUC; area under the concentration-versus-time curve; CC50; 50% cytotoxicity concentration; CL; clearance; CPE; cytopathic effect; D; distributio
Keywords: نورآمینیداز; Equine influenza virus; H3N8; Surveillance; Antigenic cartography; Neuraminidase;
Keywords: نورآمینیداز; Pyrosequencing; Matrix gene; Neuraminidase; Inhibition assays;
Keywords: نورآمینیداز; Influenza; Neuraminidase; Amino acid; Caffeic acid;
Keywords: نورآمینیداز; Flemingia philippinensis; Neuraminidase; Prenylated isoflavone; Flemingsin;
Keywords: نورآمینیداز; CNRL; Community Network of Reference Laboratories for Human Influenza in Europe; ECDC; European Centre for Disease Prevention and Control; EEA; European Economic Area; EISN; European Influenza Surveillance Network; EQA; External Quality Assessment; EU; Eu
Keywords: نورآمینیداز; Virus-like particle; Influenza vaccine; M1 immunodominant epitopes; Adenoviral dodecahedron; Cell-mediated immunity; aa; amino acid; Ad; adenovirus; Ad3; adenovirus serotype 3; APC; antigen-presenting cells; CTL; cytotoxic T lymphocyte; Dd; dodecahedron;
Keywords: نورآمینیداز; Ag; antigen; APC; antigen-presenting cells; AIV; avian influenza virus; BM; bone marrow; BALT; bronchus-associated lymphoid tissue; CG; chicken galectin; cLL; chicken lung lectin; CLR; C-type lectin receptors; DC; dendritic cells; DC-SIGN; DC-specific int
Keywords: نورآمینیداز; Ab; antibody; AIV; avian influenza virus; (BM)-DC; (bone marrow-derived) dendritic cell; BPL; beta-propiolactone; CLR; C-type lectin; DC-SIGN; dendritic cell-specific intercellular adhesion molecule-3-grabbing non-integrin; HA; haemagglutinin; HP; highly
Keywords: نورآمینیداز; Caffeic acid; Influenza; Inhibitor; Neuraminidase;
Keywords: نورآمینیداز; HA; hemagglutinin; NA; neuraminidase; IAV; influenza A virus; AIV; avian influenza virus; PB1, PB2, and PA; polymerase complex; NP; nucleoprotein; M; matrix; M2; matrix 2; NS; non-structural; NEP; nuclear export protein; MatAb; maternal antibody; SA; sial
Keywords: نورآمینیداز; Antiviral; Influenza; Nitric oxide; Pandemic; Neuraminidase;
Keywords: نورآمینیداز; Neuraminidase; Ganoderic acids; Interactions; Docking; Molecular dynamics; MM/PBSA
Self-enzyme chemiluminescence immunoassay capable of rapidly diagnosing the infection of influenza A (H1N1) virus
Keywords: نورآمینیداز; Influenza A virus; Enzyme immunoassay; Neuraminidase; Chemiluminescence; Nanocomposites; 4-Methylumbelliferyl-N-acetyl-α-D-neuraminic acid (MUNANA); 1,1â²-Oxalyldiimidazole (ODI);
Spread of predominant neuraminidase and hemagglutinin co-mutations in the influenza A/H3N2 virus genome
Keywords: نورآمینیداز; Influenza; Co-mutation; Neuraminidase; Hemagglutinin;
Electrochemical biosensors for influenza virus a detection: The potential of adaptation of these devices to POC systems
Keywords: نورآمینیداز; Influenza virus A; Electrochemical biosensors; Point of care diagnosis; Neuraminidase; Hemagglutinin;
Monoclonal antibody against N2 neuraminidase of cold adapted A/Leningrad/134/17/57 (H2N2) enables efficient generation of live attenuated influenza vaccines
Keywords: نورآمینیداز; Influenza; Neuraminidase; Monoclonal antibody; Live vaccine; Classical reassortment;
Intra-seasonal antibody repertoire analysis of a subject immunized with an MF59®-adjuvanted pandemic 2009 H1N1 vaccine
Keywords: نورآمینیداز; AA; amino acid; Ab; antibody; BCR; B cell receptor; B-mAbs; biotinylated monoclonal antibodies; BSA; bovine serum albumin; CL; clonal lineage; CVV; candidate vaccine virus; DHVI; Duke Human Vaccine Institute; DPBS; Dulbecco's Phosphate-Buffered Saline;